-60% p.a.
bt_headshoulder_sharpeopt_mixed
Introduction to our strategy no description yet Quick Summary Metric Value Return % p.a. -60 Days active 408 …
tickers: DXCM
source: Benzinga
tickers affected by this
| ticker | polarity | why? |
|---|---|---|
| DXCM | positively | The significant bullish options activity from high-net-worth investors, targeting a price range from $65.00 to $95.00, suggests strong confidence in the stock’s future performance, which could drive the ticker upwards and indicate upcoming catalysts, one of which is an anticipated earnings release in 44 days. This optimism from substantial investors could potentially lead to further price appreciation due to increased market interest. |
our strategies and bots using these tickers
None so far…
summary
DexCom (DXCM) Sees Bullish Options Activity from High-Net-Worth Investors
Investors with significant capital have taken a bullish stance on DexCom (DXCM). This was evident from the unusual options trades spotted on publicly available options history. The identity of these investors, whether institutions or wealthy individuals, remains unknown. However, such substantial trading activity often indicates that these investors anticipate significant developments for the stock.
Notable Options Trades
Price Target and Volume Analysis
Taking into account the volume and open interest on these contracts, it appears that whales have been targeting a price range from $65.0 to $95.0 for DexCom over the last three months. In today’s trading context, the average open interest for options of DexCom stands at 302.88, with a total volume reaching 1,003.00.
Notable Trades
- Bullish Call Trade: A bullish call trade with an expiration date of 03/20/26 at a strike price of $95.00, totaling $227,200.
- Bullish Put Sweep: A bullish put sweep with an expiration date of 01/16/26 at a strike price of $80.00, totaling $138,800.
- Bullish Put Trade: A bullish put trade with an expiration date of 01/16/26 at a strike price of $65.00, totaling $62,200.
About DexCom
DexCom designs and commercializes continuous glucose monitoring (CGM) systems for diabetic patients. These systems serve as an alternative to traditional blood glucose meters and are evolving to integrate with insulin pumps for automatic insulin delivery.
Current Market Position
Currently, DXCM is trading with a volume of 2,398,420, and its price is down by -1.84%, now at $69.42. RSI readings suggest the stock may be oversold. The anticipated earnings release is in 44 days.
Analyst Ratings
Over the past month, three industry analysts have shared their insights on DexCom, proposing an average target price of $96.33.
- Citigroup: Maintains a Buy rating with a price target of $104.
- Morgan Stanley: Maintains an Equal-Weight rating with a price target of $82.
- Canaccord Genuity: Maintains a Buy rating with a price target of $103. Options trading carries higher risk compared to trading the stock directly but offers higher profit potential. Serious options traders manage this risk through education, scaling in and out of trades, following multiple indicators, and closely monitoring market movements.
